Ranbaxy: Rivals Meddling With Daiichi Sankyo Deal; Congress Enters Fray
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Singh goes on TV to say global pharma industry trying to scuttle his deal.
You may also be interested in...
Ranbaxy Sees Light At The End Of DoJ Investigation Tunnel
Information Ranbaxy is giving FDA will clear its name, CEO says.
Ranbaxy Sees Light At The End Of DoJ Investigation Tunnel
Information Ranbaxy is giving FDA will clear its name, CEO says.
Ranbaxy Denies Fraudulent Conduct Alleged By U.S. FDA As Rumors Swirl About Daiichi Deal
Ranbaxy has denied U.S. FDA allegations that it conducted "systematic fraudulent conduct" related to concealing violations of current good manufacturing practices